Azathioprine (Azapress, Imuran): Uses, Dosage & Side Effects

What is Azathioprine?

Azathioprine is an immunosuppressant medication used to treat various inflammatory and autoimmune conditions. Known by brand names including Imuran®, Azasan, and Jayempi, this medication works by suppressing the body’s immune system to reduce inflammation and prevent harmful immune responses. The drug was first synthesized in 1956 by Gertrude Elion, William Lange, and George Hitchings as a derivative of 6-mercaptopurine, designed to achieve a better therapeutic profile.

Azathioprine belongs to a class of medications called antimetabolites and is available in tablet form for oral administration. The medication is only available with a doctor’s prescription and requires careful monitoring during treatment.

How Does Azathioprine Work?

Azathioprine functions as an immunosuppressive agent through multiple mechanisms within the immune system. The medication works primarily by modulating rac1 signaling to induce T cell apoptosis, or programmed cell death of T lymphocytes. T cells are a crucial component of the immune system, and by reducing their activity and number, azathioprine effectively dampens the body’s autoimmune response.

The drug suppresses disease manifestations and underlying pathology in autoimmune conditions by affecting cellular and humoral immunity differently. While cellular cytotoxicity and delayed hypersensitivity are suppressed to a greater degree, antibody responses are usually maintained at relatively normal levels. This selective immunosuppression makes azathioprine particularly valuable for treating conditions where the body’s immune system mistakenly attacks its own tissues.

Azathioprine is considered a slow-acting medication, meaning that therapeutic effects may take several weeks to become apparent after starting treatment. Additionally, effects may persist even after discontinuing the drug.

Medical Uses of Azathioprine

Azathioprine has multiple approved and established clinical applications:

• Rheumatoid Arthritis: Used to reduce signs and symptoms including joint swelling, pain, fatigue, and morning stiffness duration in patients with active rheumatoid arthritis, particularly when other medications have not provided adequate relief.
• Kidney Transplant Rejection Prevention: Administered as an adjunct therapy to prevent rejection of transplanted kidneys in patients who have undergone renal transplantation.
• Inflammatory Bowel Disease: Utilized in treating Crohn’s disease and ulcerative colitis, conditions characterized by chronic inflammation of the digestive tract.
• Multiple Sclerosis: Used in some multiple sclerosis patients, particularly those experiencing difficulties with standard FDA-approved MS medications.
• Other Autoimmune Conditions: Applied to various skin conditions and other immune-mediated disorders affecting different body systems.

Dosage and Administration

Initial Dosing

Azathioprine is available in 50 mg tablets. Treatment typically begins at a low dose, which is gradually increased over time based on patient response and tolerance. For rheumatoid arthritis patients, the initial dose is usually 50 to 100 mg given as a single dose or divided into twice-daily doses.

Dose Escalation

Dose increments should begin at 6 to 8 weeks after starting treatment and continue at 4-week intervals if no serious toxicities occur and the initial response is unsatisfactory. Dose increases should be made in increments of 0.5 mg/kg daily, not exceeding a maximum dose of 2.5 mg/kg per day. Your doctor carefully monitors this escalation to balance efficacy with safety.

Administration Guidelines

Azathioprine should be taken with meals to reduce the likelihood of stomach upset and gastrointestinal disturbances. This simple precaution significantly improves tolerability for many patients. The tablets are scored, allowing them to be divided if necessary for dose adjustments.

Timeline for Improvement

It can take 8 to 12 weeks after beginning azathioprine therapy before you notice improvement in arthritis symptoms or other conditions being treated. An adequate therapeutic trial requires a minimum of 12 weeks of treatment, after which patients not showing improvement may be considered refractory to the medication. Patience and consistent adherence to the prescribed regimen are essential during this initiation period.

Long-term Maintenance

Once a clinical response is achieved, azathioprine may be continued long-term with careful patient monitoring. Maintenance therapy should be administered at the lowest effective dose to minimize toxicity risks. Dose reduction should be attempted gradually, with decrements of 0.5 mg/kg or approximately 25 mg daily every 4 weeks while keeping other medications constant. Unlike some medications, azathioprine can be discontinued abruptly, although delayed effects remain possible.

Side Effects and Safety Concerns

Common Side Effects

Many patients tolerate azathioprine well, but some may experience side effects. The most frequently reported adverse effect is gastrointestinal disturbance, occurring in approximately 12% of rheumatoid arthritis patients. Common gastrointestinal symptoms include:

• Nausea and vomiting
• Diarrhea
• Abdominal pain
• Loss of appetite

These symptoms often occur during the initial phases of treatment and frequently can be reduced by taking the medication in divided doses and/or after meals. In some patients, however, nausea and vomiting may be severe and accompanied by symptoms such as diarrhea, fever, malaise, and muscle pain.

Hematologic Toxicity

One of the most important safety considerations involves blood cell counts. Azathioprine may cause a decrease in blood cells, including white blood cells (leukocytes) and platelets (thrombocytes). The medication can reduce red blood cell production as well. Severe hematologic toxicities include:

• Severe leukopenia (dangerously low white blood cell count)
• Thrombocytopenia (low platelet count)
• Anemia (including macrocytic anemia)
• Pancytopenia (reduction of all blood cell types)
• Severe bone marrow suppression

These hematologic toxicities are dose-related and may be more severe in kidney transplant patients whose new organ is experiencing rejection. Very rarely, azathioprine may cause myelosuppression, a serious condition where blood cell counts drop so low that it may lead to bleeding or severe infection.

Infection Risk

Because azathioprine suppresses the immune system, patients face an increased risk of developing infections. This immunosuppression can lead to bacterial, viral, fungal, protozoal, and opportunistic infections. Patients should:

• Notify their doctor immediately if signs or symptoms of infection develop
• Avoid close contact with people who have contagious diseases
• Practice good hygiene and infection prevention measures
• Report fever, persistent cough, or other infection symptoms promptly

TPMT and NUDT15 Deficiency Testing

Some patients carry genetic variations that affect how their body processes azathioprine. Your doctor may recommend TPMT (thiopurine methyltransferase) testing to identify whether you are at higher risk for severe hematologic side effects. Patients with homozygous TPMT deficiency should use alternative therapy, while those with heterozygous deficiency require reduced dosages. Similarly, NUDT15 deficiency status may influence dosing decisions.

Malignancy Risk

Patients receiving azathioprine should be counseled regarding the potential increased risk of skin malignancies and lymphomas with long-term use. This risk must be weighed against the benefits of treating the underlying condition. Regular skin examinations and cancer screening appropriate to individual risk factors are important components of long-term monitoring.

Monitoring and Blood Tests

Regular blood work is essential for safe azathioprine therapy. The recommended monitoring schedule includes:

• Weekly monitoring: Complete blood counts including platelet counts during the first month of treatment
• Twice monthly: Blood tests during the second and third months of treatment
• Monthly or more frequently: Ongoing monitoring after the first three months, or more often if dosage adjustments or other therapy changes occur
• Every 4-8 weeks: General monitoring during maintenance therapy

Delayed hematologic suppression may occur, meaning that dangerous drops in blood cell counts can develop even after weeks of stable values. Prompt dose reduction or temporary withdrawal of the medication may become necessary if there is a rapid fall in blood cell counts or persistently low values.

Important Precautions and Contraindications

Liver Disease Considerations

Patients must inform their doctor if they have any history of:

• Alcohol abuse
• Hepatitis
• Yellow jaundice
• Liver disease

While taking azathioprine, your doctor may limit your alcohol beverage intake and check your blood to ensure you do not have Hepatitis B or C. This precaution is important because the medication is processed by the liver and may worsen existing liver disease.

Drug Interactions

Azathioprine may interact with other medications, and certain drug combinations require special monitoring or dosage adjustment. Always inform your healthcare provider about all medications, supplements, and herbal products you are taking.

Pregnancy and Nursing Considerations

Women of childbearing age taking azathioprine should discuss contraception and pregnancy planning with their healthcare provider. The medication’s safety during pregnancy requires individual assessment, and special considerations apply if breastfeeding is planned. Always consult with your doctor before becoming pregnant or while nursing.

Storage and Handling

Azathioprine tablets should be stored at room temperature away from moisture and heat. Keep the medication in its original container, and follow your pharmacist’s specific storage instructions. Do not share this medication with others, even if they have similar conditions, as individual medical circumstances differ.

Frequently Asked Questions

Q: How long does it take for azathioprine to work?

A: Most patients require 8 to 12 weeks of treatment before noticing improvement in symptoms. The medication is slow-acting, so patience and consistent use are important. An adequate therapeutic trial should last at least 12 weeks.

Q: Can azathioprine be stopped abruptly?

A: Yes, azathioprine can be discontinued abruptly if necessary. However, delayed effects are possible, meaning that some effects may continue or develop after stopping the medication. Your doctor will guide you on the best approach to discontinuing treatment.

Q: What should I do if I experience signs of infection while taking azathioprine?

A: Contact your doctor immediately if you develop fever, persistent cough, sore throat, or other infection symptoms. Because azathioprine suppresses your immune system, infections can develop more easily and may require prompt medical attention.

Q: How often will I need blood tests while taking azathioprine?

A: Blood tests are required frequently at first—weekly during the first month, then twice monthly for months two and three, followed by monthly testing during maintenance therapy. More frequent testing may be needed if your dose changes or other therapies are adjusted.

Q: Can I drink alcohol while taking azathioprine?

A: Your doctor may limit your alcohol consumption while taking azathioprine. Alcohol can stress the liver, and since azathioprine is processed by the liver, combining them requires careful monitoring. Always follow your doctor’s specific recommendations.

Q: What is the maximum dose of azathioprine?

A: The maximum recommended dose is 2.5 mg/kg per day. Your doctor will carefully determine the appropriate dose for your individual condition and monitor your response.

Q: Are there genetic tests I should have before starting azathioprine?

A: Your doctor may recommend TPMT testing to determine if you carry genetic variations that affect how your body processes azathioprine. This helps identify patients at higher risk for severe side effects and guides dosing decisions.

Q: What happens if I forget to take a dose?

A: If you remember within a reasonable timeframe, take the missed dose with food. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Never double dose. Contact your pharmacist or doctor if you have specific questions about missed doses.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

medha deb

 

Medha Deb is an editor with a master's degree in Applied Linguistics from the University of Hyderabad. She believes that her qualification has helped her develop a deep understanding of language and its application in various contexts.

Read full bio of medha deb